Here, we conclusively demonstrated in TNBC model systems that OGT was an upstream regulator of this CSC pathway in a catalytic fashion; was itself regulated by splicing factors in this tumorigenic pathway; and that a key hallmark of metabolic disease, hyperglycemia, further activated this pathway. This evidence concerns the gene OGT and metabolic disease.